SCHEMBL30845441

SCHEMBL30845441

CC(C)NC(=O)CN1CCN(C(=O)OC(C)(C)C)CC1(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
CHRM5 P08912 1/20 0.37
CHRM3 P20309 1/20 0.37
EPHX2 P34913 1/20 0.36
GPR119 Q8TDV5 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CTSK P43235 1/20 0.35
EPHX1 P07099 1/20 0.35
F2RL1 P55085 1/20 0.35
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21813993 0.81 ALDH1A1 (0.43) ALDH1A1CHRM5CHRM3KMT2AHTT
SCHEMBL2395196 0.80 EPHX2 (0.40) ALDH1A1CHRM3EPHX2GPR119KMT2A
SCHEMBL21828490 0.80 SMN1; SMN2 (0.41) ALDH1A1CHRM5CHRM3KMT2AMEN1
SCHEMBL30845396 0.79 ALDH1A1 (0.57) ALDH1A1CHRM5CHRM3EPHX2MAPT
SCHEMBL25698961 0.78 CHRM1 (0.43) ALDH1A1EPHX2GPR119KMT2AMEN1
SCHEMBL22346651 0.76 USP2 (0.41) ALDH1A1EPHX2GPR119KMT2AMEN1
SCHEMBL24069318 0.74 USP2 (0.39) ALDH1A1EPHX2GPR119KMT2AMEN1
SCHEMBL17946329 0.74 USP2 (0.39) ALDH1A1EPHX2GPR119KMT2AMEN1
SCHEMBL17789628 0.73 USP2 (0.42) ALDH1A1EPHX2GPR119KMT2AMEN1
SCHEMBL18502954 0.72 ALDH1A1 (0.39) ALDH1A1CHRM5CHRM3EPHX2GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113423711-B Thieno [3,2-B ] pyridine derivatives as UDP glycosyltransferase inhibitors and methods of use thereof 建新公司 2024-03-15 CN disclosed